We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance Seeks to Forestall EU Legislation Threat to MRI

By HospiMedica International staff writers
Posted on 26 Jul 2011
A coalition of European Parliamentarians, patient groups, leading European scientists, and the medical community are seeking to avert the serious threat posed by European Union (EU) health and safety legislation to the clinical and research use of magnetic resonance imaging (MRI).

The Alliance for MRI (Vienna, Austria) was officially launched in March 2007 in response to the implementation deadline of the EU Physical Agents 2004/40/EC (EMF) in April 2008. More...
The Alliance was founded by the European Society of Radiology (ESR; Vienna, Austria), the European Federation of Neurological Associations (Billingshurst, West Sussex, UK), and Dr. Swoboda MEP, vice-chairman of the Socialist Group in the European Parliament.

In October 2007, the European Commission recognized the problem of MRI in Directive 2004/40/EC and proposed the first-ever postponement of an implementation deadline from April 2008 to April 2012 to allow time for scientific studies to study the impact of the Directive on the use of MRI. These studies confirmed that the exposure limits in the directive were detrimental to patient care. They would restrict and limit the use of MRI in interventional applications and in imaging vulnerable patients and children where closer patient contact is required. Furthermore, new research and developments in MRI would be severely restricted, as will routine cleaning and maintenance of MRI equipment.

Following additional consultations, the Commission decided to revise the Directive in order to find a lasting solution for MR culminating in the current proposal. The Alliance for MRI was instrumental in bringing about this revision.

MRI has been used for over 25 years, imaging up to 500 million patients without evidence of harm to workers due to EMF exposure. It is also well known that MRI is free from most health risks associated with ionizing radiation such as X-rays, which would form the alternative to MRI in many situations.

MRI is central to the diagnosis and treatment of major life-threatening diseases such as cancer, cardiovascular diseases, musculoskeletal, and neurologic disorders. Emerging molecular MR imaging techniques are poised to make major contributions in the area of oncology. Currently MRI is the most accurate tool for detecting breast cancer in young patients with genetic predisposition. Cardiac MRI has made huge strides in recent years, for example allowing for the assessment of the functioning of heart muscle in heart-attack patients. Functional MRI, mapping out areas of the brain that are responsible for specific sensory and motor tasks, is making significant contributions to neuroscience as well as improving the outcome of brain surgery for patients.

Moreover, a number of individual scientists and patient group representatives have signed up to the Alliance. “This proposal is good news for patients around Europe, and we look forward to its quick adoption, which will clarify the law on MRI,” said Hannes Swoboda, a leading member of the European Parliament and founding member of the Alliance for MRI.

“Europe is currently at the forefront of this technology and with this revision the Commission demonstrated that it supports this vital technology,” said Prof. Gabriel Krestin, vice-president of the European Society of Radiology.

Related Links:

Alliance for MRI
European Society of Radiology
European Federation of Neurological Associations



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.